What is the catalog number for Ibalizumab (CD4 D3 domain) - Research Grade Biosimilar?

The catalog number for Ibalizumab (CD4 D3 domain) - Research Grade Biosimilar is 10-262.

What sizes are available for Ibalizumab (CD4 D3 domain) - Research Grade Biosimilar?

Ibalizumab (CD4 D3 domain) - Research Grade Biosimilar is available in the following size(s): 0.1 mg.

Ibalizumab (CD4 D3 domain) - Research Grade Biosimilar

Q: Is Ibalizumab (CD4 D3 domain) - Research Grade Biosimilar in stock?

Ibalizumab (CD4 D3 domain) - Research Grade Biosimilar is currently made to order / not held in immediate stock. Contact us for lead time.

Product Specifications

Background

Ibalizumab (also known as ibalizumab-uiyk and formerly known as TNX-355) is a monoclonal antibody that binds to CD4 receptors on the surface of CD4-positive cells, preventing HIV particle entry into the lymphocytes. It is an advanced and current antibody in development for the treatment of HIV/AIDS. It has been developed by Taimed biologics and Theratechnologies 8,5.

Immunogen

Humanized / CD4 D3 domain [Homo sapiens]

Clonality

Recombinant Monoclonal

Conjugation

Unconjugated

Type

Primary Antibodies, Biosimilars

Source

CHO cells

Field of Research

Infectious Disease

Purification

>95%

Concentration

Batch dependent

Buffer

PBS buffer pH7.5

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.